A transcriptional signature to quantify the fraction of PD-1hiCD8+ T cells in tumor environment. Patients with high signature scores are more likely to response to immune checkpoint inhibitors, and are associated with increased clinical outcome.
Package details |
|
---|---|
Author | Zhenyu Yang |
Maintainer | Yulan Deng <kndeajs@163.com> |
License | GPL (>= 2) |
Version | 1.0 |
Package repository | View on GitHub |
Installation |
Install the latest version of this package by entering the following in R:
|
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.